Seguir
CRISTINA SANCHEZ
CRISTINA SANCHEZ
Email confirmado em quim.ucm.es
Título
Citado por
Citado por
Ano
Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
I Galve-Roperh, C Sánchez, ML Cortés, TG del Pulgar, M Izquierdo, ...
Nature medicine 6 (3), 313-319, 2000
8322000
Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor
C Sánchez, ML de Ceballos, TG del Pulgar, D Rueda, C Corbacho, ...
Cancer research 61 (15), 5784-5789, 2001
5592001
Towards the use of cannabinoids as antitumour agents
G Velasco, C Sánchez, M Guzmán
Nature Reviews Cancer 12 (6), 436-444, 2012
5032012
A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
M Guzman, MJ Duarte, C Blazquez, J Ravina, MC Rosa, I Galve-Roperh, ...
British journal of cancer 95 (2), 197-203, 2006
4442006
Δ9‐Tetrahydrocannabinol induces apoptosis in C6 glioma cells
C Sánchez, I Galve-Roperh, C Canova, P Brachet, M Guzmán
FEBS letters 436 (1), 6-10, 1998
3481998
Control of the cell survival/death decision by cannabinoids
M Guzmán, C Sánchez, I Galve-Roperh
Journal of molecular medicine 78 (11), 613-625, 2001
2922001
Anticancer mechanisms of cannabinoids
G Velasco, C Sánchez, M Guzmán
Current Oncology 23 (2), S23, 2016
2882016
Δ9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation
MM Caffarel, D Sarrió, J Palacios, M Guzmán, C Sánchez
Cancer research 66 (13), 6615-6621, 2006
2832006
Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Δ9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary …
C Sánchez, I Galve-Roperh, D Rueda, M Guzmán
Molecular Pharmacology 54 (5), 834-843, 1998
2471998
De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis
TG del PULGAR, G Velasco, C Sánchez, H Amador, M Guzmán
Biochemical Journal 363 (1), 183-188, 2002
2322002
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
MM Caffarel, C Andradas, E Mira, E Pérez-Gómez, C Cerutti, ...
Molecular cancer 9 (1), 1-11, 2010
2312010
Cannabinoids and cell fate
M Guzmán, C Sánchez, I Galve-Roperh
Pharmacology & therapeutics 95 (2), 175-184, 2002
2212002
The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK
C Andradas, MM Caffarel, E Perez-Gomez, M Salazar, M Lorente, ...
Oncogene 30 (2), 245-252, 2011
2202011
Ceramide: a new second messenger of cannabinoid action
M Guzmán, I Galve-Roperh, C Sánchez
Trends in pharmacological sciences 22 (1), 19-22, 2001
1842001
Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55
CM Henstridge, NAB Balenga, J Kargl, C Andradas, AJ Brown, A Irving, ...
Molecular Endocrinology 25 (11), 1835-1848, 2011
1702011
Cannabinoids: a new hope for breast cancer therapy?
MM Caffarel, C Andradas, E Pérez-Gómez, M Guzmán, C Sánchez
Cancer treatment reviews 38 (7), 911-918, 2012
1482012
The CB1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan
C Sánchez, D Rueda, B Ségui, I Galve-Roperh, T Levade, M Guzmán
Molecular Pharmacology 59 (5), 955-959, 2001
1452001
Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling
E Moreno, C Andradas, M Medrano, MM Caffarel, E Pérez-Gómez, ...
Journal of Biological Chemistry 289 (32), 21960-21972, 2014
1322014
Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study
E Murillo-Rodriguez, C Blanco-Centurion, C Sanchez, P Daniele, ...
Sleep 26 (8), 943-947, 2003
1262003
Effects of cannabinoids on energy metabolism
M Guzmán, C Sánchez
Life sciences 65 (6), 657-664, 1999
1191999
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20